Download
Printer Friendly
|
|||||||||||||||||||||||||||||
Joel D. Becker, was appointed as Chief Executive Officer and Director of NeuroPace, Inc., effective July 10, 2023. Mr. Becker most recently served as President at Viking North Ventures, a firm providing advisory services to medical technology and healthcare companies and investors, from October 2022 to July 2023, in which role he was responsible for providing advisory, leadership and strategy development services. From April 2019 to October 2022, Mr. Becker served as President of the Cardiac Rhythm Management and Neuromodulation product category of Integer Holdings Corporation, a global medical device company, in which role he was responsible for overseeing commercial and operational strategy and execution. Prior to joining Integer, Mr. Becker served as Chief Executive Officer of Xchange Labs, LLC, a healthcare technology SaaS company that develops connectivity products and services focused on providing caregivers access to patient management data and integration with health plan medication management services, from May 2017 to August 2018, in which role he was responsible for commercial and operational execution. From 2004 to 2016, Mr. Becker served in various leadership roles at St. Jude Medical, a global medical device manufacturer acquired by Abbott Laboratories in 2017, including President, Americas Division, from 2013 to 2016, and President, United States Division, from 2011 to 2013. Mr. Becker earned a B.A. in Business Administration from Augustana College and an M.B.A from the University of Minnesota.
| Master |
| Bachelor |
| Business Administration |
| Insider Holdings - Transactions | Detailed Insider Activity |
|---|
| Issuer's Name | Trans. Date | Form | Action | Price | Mkt Value | D/I | Shares | Holdings |
|---|---|---|---|---|---|---|---|---|
| Neuropace Inc | 02/27/2024 | 4 | A | 0.00 | 0 | D | 52,470 | 52,470 |